{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:27:14Z","timestamp":1761128834291},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jbspin.2010.05.011","type":"journal-article","created":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T20:37:43Z","timestamp":1278880663000},"page":"564-569","source":"Crossref","is-referenced-by-count":13,"title":["Outcome and safety of TNF\u03b1 antagonist therapy in 475\u00a0consecutive outpatients (with rheumatoid arthritis or spondyloarthropathies) treated by a single physician according to their eligibility for clinical trials"],"prefix":"10.1016","volume":"77","author":[{"given":"Jean-Marie","family":"Berthelot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Benoist-G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"le Goff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Muller-Chevalet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Maugars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2010.05.011_bib0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jbspin.2007.10.002","article-title":"TNF-alpha antagonists in rheumatoid arthritis patients seen in everyday practice","volume":"74","author":"Falgarone","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/art.10817","article-title":"Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis","volume":"48","author":"Sokka","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0015","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/ard.2007.072447","article-title":"The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomized controlled trials and clinical practice","volume":"66","author":"Kievit","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.amjmed.2008.02.018","article-title":"TNF antagonist responsiveness in a United States rheumatoid arthritis cohort","volume":"121","author":"Greenberg","year":"2008","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.jbspin.2010.05.011_bib0025","first-page":"S764","article-title":"Fit for study: eligibility of veterans with rheumatoid arthritis in major clinical trials of biological therapies","volume":"58 Suppl.","author":"Hooker","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jbspin.2008.03.006","article-title":"Six-month response to anti-TNF drugs in axial spondylarthropathy according to the fulfillment or not of New-York criteria for ankylosing spondylitis or French recommendations for anti-TNF use. A \u201creal life\u201d retrospective study on 175\u00a0patients","volume":"75","author":"G\u00e9rard","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/rheumatology\/ken034","article-title":"Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment group Register","volume":"47","author":"Karlsson","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0040","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/rheumatology\/kel333","article-title":"BSR Biologic Register Management committee. UK consultant rheumatologists\u2019 access to biological agents and views on the BSR biologic register","volume":"45","author":"Kay","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/03009740601089267","article-title":"Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results form the nationwide Danish DANBIO database","volume":"36","author":"Ostergaard","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0050","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar1941","article-title":"Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER","volume":"8","author":"Carmona","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0055","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents","volume":"301","author":"Strangfeld","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0060","article-title":"Evaluating guidelines of continuation of anti-TNF treatment after three months: clinical, effectiveness and costs of observed care and different alternative strategies","author":"Kievit","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1185\/030079906X80341","article-title":"Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid arthritis disease-modifying anti-rheumatic drug intervention and utilization study) study","volume":"22","author":"Gibofsky","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0070","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/rheumatology\/ken348","article-title":"Eligibility of rheumatoid arthritis patients for anti-TNF-alpha therapy according to the 2005 recommendations of the French and British Societies for Rheumatology","volume":"47","author":"Fautrel","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/rheumatology\/ken094","article-title":"Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis","volume":"47","author":"Coates","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0080","first-page":"85","article-title":"Criteria of the classification of spondylarthropathies","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0090","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.1780290216","article-title":"A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis","volume":"29","author":"Cassidy","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0889-857X(02)00033-9","article-title":"The juvenile-onset spondyloarthritides","volume":"28","author":"Burgos-Vargas","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jbspin.2006.04.001","article-title":"Recommendations of the French Society for Rheumatology. TNFalpha antagonist therapy in rheumatoid arthritis","volume":"73","author":"Fautrel","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0105","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jbspin.2007.10.003","article-title":"Recommendations of the French Society for Rheumatology regarding TNF alpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update","volume":"74","author":"Pham","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1526-4637.2006.00203.x","article-title":"A critical analysis of the tender points in fibromyalgia","volume":"8","author":"Harden","year":"2007","journal-title":"Pain Med"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.21570","article-title":"The LUNDEX, a new index of drug efficacy in clinical practice: results of a five year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden","volume":"54","author":"Kristensen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/art.22613","article-title":"Daily health status registration (patient diary) in patients with rheumatoid arthritis: a comparison between personal digital assistant and paper-pencil format","volume":"57","author":"Heiberg","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jbspin.2007.05.018","article-title":"High intra-individual week-to-week variability in BASDAI and BASFI values: are several evaluations needed before starting or stopping TNFalpha antagonist therapy for spondylarthropathies?","volume":"5","author":"Berthelot","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jbspin.2008.11.009","article-title":"Effect of discontinuing TNFalpha antagonist therapy in patients with remission of rheumatoid arthritis","volume":"76","author":"Brocq","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jbspin.2007.04.013","article-title":"Impact of etanercept on the costs of rheumatoid arthritis (RA): results from a French observational study","volume":"75","author":"Juillard-Condat","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.18553\/jmcp.2006.12.7.555","article-title":"Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis","volume":"12","author":"Doan","year":"2006","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0145","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1002\/art.22193","article-title":"Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials","volume":"54","author":"Zink","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0150","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0149-2918(08)80063-X","article-title":"Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis","volume":"30","author":"Tang","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/rheumatology\/ken034","article-title":"Treatment response to a second or third TNF-inhibitor in RA: results from the south Swedish arthritis treatment group register","volume":"47","author":"Karlsson","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.22552","article-title":"A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology Response","volume":"57","author":"American College of Rheumatology Committee to reevaluate improvement criteria","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"Van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0170","first-page":"705","article-title":"ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology","volume":"26","author":"Van Gestel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0175","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/ard.2008.092353","article-title":"Methods of deriving EULAR\/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis","volume":"67","author":"Karonitsch","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0180","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/ard.2004.027649","article-title":"Response criteria for rheumatoid arthritis in clinical practice: how useful are they?","volume":"64","author":"G\u00fclfe","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0185","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/art.20995","article-title":"Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria","volume":"52","author":"Pincus","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0190","first-page":"696","article-title":"Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes","volume":"34","author":"Caplan","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0195","first-page":"1141","article-title":"Premature immunosenescence in rheumatoid arthritis","volume":"29","author":"Weyand","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.05.011_bib0200","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/art.23599","article-title":"Premature aging of the immune system in children with juvenile idiopathic arthritis","volume":"58","author":"Prelog","year":"2008","journal-title":"Arthritis Rheum"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10001661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10001661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T01:51:30Z","timestamp":1635645090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X10001661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1297319X10001661"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2010.05.011","relation":{},"ISSN":["1297-319X"],"issn-type":[{"type":"print","value":"1297-319X"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}